Martin Heidecker

Martin Heidecker

Chief Investment Officer atAMR Action FundBoston

Martin Heidecker joined the AMR Action Fund in August 2021. He previously worked at Boehringer Ingelheim Venture Fund, Bayern Kapital, Solvay Pharmaceuticals, and holds degrees from University of Würzburg and FernUniversität Hagen.

What Martin can write

Writes checks ofNot reported
Comes in atNot reportedCan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. Bayern Kapital
  2. Solvay Pharmaceuticals · Business Development and Marketing
  3. Boehringer Ingelheim · Business Development and Marketing
  4. Boehringer Ingelheim Venture Fund · Managing Director USA
  5. AMR Action Fund · Chief Investment Officer
    Now

Investments named in public bios

Tilos Therapeutics Inc.Armagen Technologies

Focus

venture capitaldrug developmentpharmaceutical marketingoncologyanti-infectivesseed investments

Education

University of Würzburg, PhD in biologyFernUniversität Hagen, MBAUniversity of Wurzburg, PhD in biologyFern Universitat Hagen, MBA

Also at AMR Action Fund

Alert me when AMR Action Fund is active

One email when Martin's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Martin Heidecker?

Martin Heidecker joined the AMR Action Fund in August 2021. He previously worked at Boehringer Ingelheim Venture Fund, Bayern Kapital, Solvay Pharmaceuticals, and holds degrees from University of Würzburg and FernUniversität Hagen.

How much does Martin Heidecker invest?

AMR Action Fund has not reported a check size.

How do I pitch Martin Heidecker?

A warm intro from a founder AMR Action Fund backed works best.

What did Martin Heidecker do before AMR Action Fund?

Bayern Kapital; Business Development and Marketing at Solvay Pharmaceuticals; Business Development and Marketing at Boehringer Ingelheim; Managing Director USA at Boehringer Ingelheim Venture Fund.

Last updated 2026-10-15. Is this you? Ask for a correction.